Cordova is the trade name and generic name of Doxazosin Mesylate Extended-Release Tablets, which is mainly used in the symptomatic treatment of Benign Prostatic Hyperplasia (BPH) and the treatment of hypertension. It has certain therapeutic effects on the above conditions. Clinically, Doxazosin Mesylate is a commonly used drug for the treatment of prostate hyperplasia. It can effectively improve the symptoms of frequent urination, urgent urination and poor urination caused by prostate hyperplasia. In addition, in the human body, Doxazosin Mesylate can antagonize phenylephrine (α1 agonist) prostate contraction, and can reduce peripheral vascular resistance to lower blood pressure. Patients may experience adverse reactions, such as dizziness, headache, and urinary incontinence, while using Doxazosin Mesylate Extended-Release Tablets. It should also be contraindicated in people who are allergic to quinazolines and any of the components of the drug or who have a history of any degree of narrowing of the luminal diameter of the gastrointestinal tract. Patients with prostate enlargement should visit the hospital in time to clarify the contraindications of the drug and use it under the guidance of a doctor.